Nobuko Hongo

523 total citations
10 papers, 373 citations indexed

About

Nobuko Hongo is a scholar working on Biochemistry, Dermatology and Sensory Systems. According to data from OpenAlex, Nobuko Hongo has authored 10 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biochemistry, 2 papers in Dermatology and 2 papers in Sensory Systems. Recurrent topics in Nobuko Hongo's work include Antioxidant Activity and Oxidative Stress (5 papers), Skin Protection and Aging (2 papers) and Olfactory and Sensory Function Studies (2 papers). Nobuko Hongo is often cited by papers focused on Antioxidant Activity and Oxidative Stress (5 papers), Skin Protection and Aging (2 papers) and Olfactory and Sensory Function Studies (2 papers). Nobuko Hongo collaborates with scholars based in Japan, Canada and United Kingdom. Nobuko Hongo's co-authors include Kumi Tominaga, Eiji Yamashita, Yu Takahashi, Hiroshi Watarai, T. Tashiro, M. Taniguchi, Nyambayar Dashtsoodol, Yusaku Takamura, Hisao Nishijo and Takashi Saito and has published in prestigious journals such as The FASEB Journal, Frontiers in Pharmacology and International Immunology.

In The Last Decade

Nobuko Hongo

7 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuko Hongo Japan 7 131 81 79 68 62 10 373
Kumi Tominaga Japan 5 137 1.0× 6 0.1× 62 0.8× 75 1.1× 66 1.1× 8 302
Shota Sakai Japan 13 20 0.2× 87 1.1× 243 3.1× 18 0.3× 36 0.6× 28 438
Heidi Brenden Germany 9 32 0.2× 38 0.5× 103 1.3× 240 3.5× 9 0.1× 16 426
Don‐Gil Lee South Korea 14 27 0.2× 36 0.4× 178 2.3× 112 1.6× 17 0.3× 19 416
Heon‐Sub Shin South Korea 12 40 0.3× 26 0.3× 152 1.9× 123 1.8× 16 0.3× 19 378
Toshio Horikoshi Japan 12 35 0.3× 35 0.4× 92 1.2× 99 1.5× 6 0.1× 17 388
Liyang Kang China 9 41 0.3× 34 0.4× 152 1.9× 167 2.5× 4 0.1× 11 456
Yujie Ouyang China 9 50 0.4× 42 0.5× 153 1.9× 143 2.1× 4 0.1× 14 414
Malwina Zasada Poland 7 46 0.4× 19 0.2× 85 1.1× 173 2.5× 6 0.1× 12 303
Marielle Moreau France 12 20 0.2× 15 0.2× 223 2.8× 85 1.3× 7 0.1× 24 379

Countries citing papers authored by Nobuko Hongo

Since Specialization
Citations

This map shows the geographic impact of Nobuko Hongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Hongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Hongo more than expected).

Fields of papers citing papers by Nobuko Hongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuko Hongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Hongo. The network helps show where Nobuko Hongo may publish in the future.

Co-authorship network of co-authors of Nobuko Hongo

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuko Hongo. A scholar is included among the top collaborators of Nobuko Hongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuko Hongo. Nobuko Hongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hongo, Nobuko, Yusaku Takamura, Hiroshi Nishimaru, et al.. (2020). Astaxanthin Ameliorated Parvalbumin-Positive Neuron Deficits and Alzheimer’s Disease-Related Pathological Progression in the Hippocampus of AppNL-G-F/NL-G-F Mice. Frontiers in Pharmacology. 11. 307–307. 31 indexed citations
2.
Hongo, Nobuko. (2017). Daily Fatigue—reducing Effect of Astaxanthin―A Randomized, Placebo—controlled, Double—blind, Parallel—group Study―. 45(1). 61–72. 7 indexed citations
3.
Tominaga, Kumi, et al.. (2017). Protective effects of astaxanthin on skin deterioration. Journal of Clinical Biochemistry and Nutrition. 61(1). 33–39. 73 indexed citations
4.
Takahashi, Jiro, et al.. (2015). The Safety of AstaREAL, an Astaxanthin Product Derived from <i>Haematococcus pluvialis</i><b></b>. 12(1). 9–17. 1 indexed citations
5.
Yamashita, Eiji, Nobuko Hongo, & Kumi Tominaga. (2014). Astaxanthin ameliorates UVB‐induced inflammation in keratinocytes and keratinocyte‐dependent MMP‐1 production in fibroblasts in vitro (645.2). The FASEB Journal. 28(S1). 1 indexed citations
6.
Nagata, Koji, Nobuko Hongo, Akihiro Yamamura, et al.. (2013). The structure of brazzein, a sweet-tasting protein from the wild African plantPentadiplandra brazzeana. Acta Crystallographica Section D Biological Crystallography. 69(4). 642–647. 15 indexed citations
7.
Tominaga, Kumi, et al.. (2012). Cosmetic benefits of astaxanthin on humans subjects.. Acta Biochimica Polonica. 59(1). 43–7. 159 indexed citations
8.
Tashiro, T., Tomokuni Shigeura, Ryusuke Nakagawa, et al.. (2010). Induction of Th1-biased cytokine production by  -carba-GalCer, a neoglycolipid ligand for NKT cells. International Immunology. 22(4). 319–328. 32 indexed citations
9.
Taniguchi, M., T. Tashiro, Nyambayar Dashtsoodol, Nobuko Hongo, & Hiroshi Watarai. (2009). The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. International Immunology. 22(1). 1–6. 54 indexed citations
10.
Watanabe, Kensuke, et al.. (1963). [CASE OF JAUNDICE CAUSED BY ADMINISTRATION OF ANABOLIC STEROIDS].. PubMed. 12. 377–80.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026